CD1 activators comprise a unique class of chemical compounds specifically designed to elevate or enhance the activity or expression of CD1 proteins. These glycoproteins, primarily displayed on the surface of specific antigen-presenting cells, are instrumental in lipid antigen presentation. By understanding and modulating their activity, researchers gain crucial insights into certain lipid-mediated immune responses.
Direct activators within this class are tailored to have an affinity for the CD1 protein. Their mode of action is centered around forming a direct interaction, typically a binding event, with the CD1 protein. This binding event could stabilize the protein, potentiate its intrinsic function, or trigger a cascade of events amplifying its activity within the cell. The molecular architecture of these activators is carefully crafted to ensure optimal engagement with CD1, emphasizing specificity and the resulting amplification of function. In contrast, indirect activators, while not interacting with the CD1 protein directly, induce conditions or cellular responses that culminate in an upregulation of CD1 activity or expression. This might involve stimulating pathways leading to increased transcription of the CD1 genes, modulating protein stability mechanisms, or influencing other cellular components that indirectly boost CD1 function.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $74.00 $118.00 | 8 | |
A retinoid known to influence cell differentiation and could potentially influence CD1 expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
A PKC activator which could indirectly upregulate certain immune-related proteins. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $240.00 | 9 | |
Another PKC activator with potential implications on immune response modulation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A calcium ionophore which could affect calcium-dependent signaling pathways linked to CD1 expression. | ||||||
Zymosan | 9010-72-4 | sc-296863 sc-296863A | 100 mg 1 g | $97.00 $587.00 | 1 | |
A polysaccharide that activates complement and might indirectly influence antigen-presenting cell functions. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Known to modulate immune responses, which might indirectly affect CD1 expression. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $76.00 $148.00 | 9 | |
Immunosuppressive which can influence T-cell function and, by extension, potentially affect CD1 dynamics. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $96.00 $166.00 $459.00 $1615.00 | 12 | |
As an immune stimulant, LPS might have downstream implications for CD1 expression in certain antigen-presenting cells. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
It's known to influence immune cell function and differentiation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Known to affect glycogen synthase kinase-3β, potentially influencing immune cell function. | ||||||